Speaker illustration

Doctor Christian Schulte

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

Dr. Christian Schulte is a clinician scientist in cardiology, working in the translational interface between noncoding RNA biology and their clinical implications i.e. as circulating biomarkers in cardiovascular disease. He started his research in parallel to his clinical training at the University Heart Center Hamburg, Germany, where his research interest focused on circulating microRNAs. In 2016 he was awarded a two-year research fellowship by the German Research Foundation (DFG) to join the group of Prof. Manuel Mayr at King’s College London, where he pursued a project on circulating noncoding RNAs compared to protein biomarkers in cardiovascular disease and the potential of clinical implementation as biomarkers, embedded in a PhD programme. Currently, Dr. Schulte is building up his own research group in Hamburg, alongside completing his clinical training.

Circulating hexose-derived metabolites are biomarker candidates for diabetes risk prediction

Event: ESC Congress 2023

Topic: Biomarkers

Session: Metabolic risk, exercise, and heart disease

Thumbnail

Circulating metabolites are biomarker candidates for stroke risk prediction as assed in a europe-wide population cohort (biomarcare)

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Stroke from ischaemic to bleeding events

Thumbnail

VEGF beta is a candidate biomarker for cardiovascular risk stratification

Event: ESC Congress 2022

Topic: Biomarkers

Session: Biomarkers and more

Thumbnail

Exosomes and circulating RNAs as biomarker for cardiovascular disease.

Event: ESC Congress 2019

Topic: Basic Science

Session: Precision medicine: novel biomarkers for patient risk stratification

Thumbnail

A comparative analysis of circulating non-coding RNAs versus protein biomarkers in the detection of myocardial injury

Event: ESC Congress 2019

Topic: Genetics, Epigenetics, ncRNA

Session: Extracellular vesicles and cell communication in cardiovascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb